Filing Details

Accession Number:
0001104659-19-046520
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-19 16:16:03
Reporting Period:
2019-08-16
Accepted Time:
2019-08-19 16:16:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1720893 Bioxcel Therapeutics Inc. BTAI Pharmaceutical Preparations (2834) 821386754
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1733369 Vimal Mehta C/O Bioxcel Therapeutics, Inc.,
555 Long Wharf Drive
New Haven CT 06511
Ceo, President And Secretary Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-16 974 $8.89 9,957 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were acquired in multiple transactions at prices ranging from $8.73 to $9.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.